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Summary
Known examples of ancient identical-by-descent genetic variants being shared between evolutionarily related
species, known as trans-species polymorphisms (TSPs), result from counterbalancing selective forces acting on
target genes to confer resistance against infectious agents. To date, putative TSPs between humans and other
primate species have been identified for the highly polymorphic major histocompatibility complex (MHC), the
histo-blood ABO group, two antiviral genes (ZC3HAV1 and TRIM5), an autoimmunity-related gene LAD1 and
several non-coding genomic segments with a putative regulatory role. Although the number of well-characterized
TSPs under long-term balancing selection is still very small, these examples are connected by a common thread,
namely that they involve genes with key roles in the immune system and, in heterozygosity, appear to confer
genetic resistance to pathogens. Here, we review known cases of shared polymorphism that appear to be under
long-term balancing selection in humans and the great apes. Although the specific selective agent(s) responsible
are still unknown, these TSPs may nevertheless be seen as constituting important adaptive events that have
occurred during the evolution of the primate immune system.
Introduction
Trans-species polymorphisms (TSPs) are ancient genetic
variants whose origin predates speciation events, result-
ing in shared alleles between evolutionarily related spe-
cies [1]. Shared polymorphisms are only considered to
be TSPs sensu stricto when there is convincing evidence
to show that they are identical-by-descent rather than
recurrent mutations occurring independently in different
lineages (i.e. identical-by-state); the latter often involve
the CpG dinucleotide [2, 3] whose hypermutability is
directly attributable to its role as the major site of cytosine
methylation, with the attendant risk of spontaneous de-
amination of 5-methylcytosine to yield thymine. It follows
that, even in a genomic region which manifests signals of
balancing selection, a specific shared polymorphism that
is located within a CpG dinucleotide is, by its very nature,
more likely to be identical-by-state due to recurrent
mutation in distinct lineages rather than it is to be
identical-by-descent. In such cases, any of the strong
signals of balancing selection observed may emanate
from functionally relevant balanced polymorphisms
that are closely linked to the CpG site in question but
which are not themselves shared across lineages.
The long-term (i.e. post-speciation) preservation of
bona fide identical-by-descendent TSPs is inherently
unlikely under a purely neutralist model of evolution
[4, 5], and hence the action of selection must invariably
be assumed. In passing, it should be noted that positive
selection is also implicit in the case of independently
occurring identical-by-state polymorphisms in different
lineages. Here, we review the small number of relatively
well-characterized examples of TSPs that are shared be-
tween the genomes of great apes (human, common
chimpanzee, bonobo, gorilla and orangutan), focusing
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specifically on those for which there is a body of evi-
dence for long-standing balancing selection (Fig. 1).
TSPs maintained by balancing selection: the MHC and
ABO loci
Evidence for the common ancestral origin of an ex-
tant TSP shared by humans and one or more of the
great apes was first documented about three decades
ago when orthologous sequences from the highly
polymorphic major histocompatibility complex (MHC)
loci were compared between species [4, 6]. MHC (known
as HLA, human leucocyte antigen, in humans) loci play a
key role in the adaptive response to pathogens [7, 8],
and some of the allelic lineages of the human HLA-DQ
alpha locus (HLA-DQA1, HLA-DQA3 and HLA-
DQA4) were deduced to have been present in the most
recent common ancestor of the human, chimpanzee
and gorilla lineages [4] and must therefore have sur-
vived for at least 8 million years [9, 10]. More recently,
the human MHC lineage most strongly associated with
delayed HIV-1 progression (HLA-B*57) was found to
exhibit a high degree of similarity to a lineage fre-
quently found among SIV-infected chimpanzees [11].
Other comparisons have reached a similar conclusion,
namely that many alleles at the MHC locus have sur-
vived for an extended period of evolutionary time and
hence are currently shared by multiple primate line-
ages. One example is provided by the MHC-DQB1*06
allele which predates the separation of the hominid and
Old World monkey lineages more than 35 million years
ago [12]. Shared alleles at the MHC locus have also
been found in other primates such as the rhesus and
cynomolgous macaques [13], between Madagascan le-
murs in which some alleles appear to have been main-
tained for more than 40 million years [14] and between
several non-primate lineages such as mice and rats
[15], the brown bear (Ursus arctos) and the giant panda
(Ailuropoda melanoleuca) [16], South American mouse
opossums (Gracilinanus microtarsus and Marmosops
incanus) [17] and between equines [18] among others
(reviewed in [19]). The maintenance of these shared
polymorphisms over such extended periods of evolu-
tionary time implies strong selective pressure on the
host immune response elicited by the pathogenic agent.
However, it should be borne in mind that the potential
contribution of recurrent mutation to the origin of
these shared variants has not always been unequivocally
excluded. It may therefore be that some of these ‘shared
variants’ are actually identical-by-state rather than
identical-by-descent. At the same time, direct evidence
for a functional role for the balanced variant, or group
of variants, is lacking in most cases. Although these
caveats do not necessarily challenge the now well-
established role of balancing selection acting on MHC
loci, it precludes the acquisition of a clear picture of
how often the TSPs are actually identical-by-descent as
opposed to simply being identical-by-state.
Another well-established example of long-term balan-
cing selection operating in the primate genome is pro-
vided by the ABO blood group locus. In humans, three
main alleles account for the diversity at this locus, corre-
sponding to the A, B and O blood groups. The A and B
Fig. 1 Known examples of trans-species polymorphisms maintained by long-term balancing selection in humans and the great apes
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alleles are functionally distinguished by the co-occurrence
of two missense mutations (Leu266Met and Gly268Ala,
respectively) in the encoded glycosyltransferase whereas
the human O allele results from an inactivating single-
nucleotide deletion (261delG) that impairs enzymatic
function, resulting in failure to convert H antigen into A
or B [20]. A and B alleles are shared between humans and
non-human primates [21–23]. Although one of the alleles
has been lost in some lineages during great ape speciation
(e.g. common chimpanzees and bonobos exhibit only the
A antigen, whereas the gorilla harbours the B antigen),
other lineages have retained both the A and B identical-
by-descent alleles, e.g. the orangutan which shared a com-
mon ancestor with humans more than 16 million years
ago [24]. Although pathogen-driven selective pressure
operating on the balanced A/B alleles appears less in-
tuitive than it perhaps is for the MHC locus, one must
recall that there are several instances of histo-blood
group antigens being associated with differential pro-
tection against multiple infectious microbes [25–27].
For example, infection by Helicobacter pylori has been
shown to be reduced in A and B blood types as com-
pared with carriers of the O type [25]. Moreover, a link
between pathological conditions associated with H.
pylori colonization, such as gastric [28, 29] and pancre-
atic cancer [30, 31], and the ABO phenotype has also
been established in humans. Assuming that the persist-
ence of the A/B polymorphism is maintained by
pathogen-driven balancing selection, one may reason-
ably extend these considerations to the other great ape
species.
Beyond the MHC and ABO loci
Apart from the well-established examples of trans-
species polymorphisms at the MHC and ABO loci
which are maintained by balancing selection, few
other properly substantiated examples of TSPs have
been documented. One particularly interesting case is
provided by the zinc-finger CCCH-type antiviral pro-
tein 1 (ZC3HAV1, also known as poly(ADP-ribose)
polymerase 13-PARP13), a protein that is known to
protect host cells from viral infection [32–35] and
cellular stress [36]. The ZC3HAV1 polymorphic sub-
stitution Thr851Ile (rs3735007) is shared between
humans and common chimpanzees and does not
occur in a hypermutable CpG site (Table 1), support-
ing its candidacy as a true TSP [37]; an exhaustive
analysis of the genomic region adjacent to this TSP
has shown that the polymorphism has been selectively
maintained in both species, probably as a result of its
broad protective effect against viral infection.
Another potential example of trans-species poly-
morphism under balancing selection is provided by the
TRIM5 gene. This gene also encodes an antiviral pro-
tein [38–40] (TRIM5, tripartite motif-containing 5),
one that is known to act as a blocking factor of HIV-1
reverse transcription thereby limiting the efficiency of
the infection in primates [41]. In non-primate species,
TRIM5 is also active as an antiviral protein [42–45]
and the reconstruction of TRIM5 evolutionary history
has provided evidence for a long-term interaction with
several different viruses prior to the origin of primate
lentivirus [46].
A previous study has evidenced balanced TSPs in
the primate TRIM5 genes [47]. In a separate investi-
gation, two intragenic TRIM5 polymorphisms were
found to be shared between human and common
chimpanzee (Table 1): an intron 1-CTC insertion/deletion
and an intron 1 transition (rs34506684), the latter occur-
ring at an CpG dinucleotide [48]. Although the func-
tional significance of these variants has not yet been
established, the authors suggested that the intron 1
variant rs34506684 might impact transcription factor-
binding sites leading to allelic differences in transcrip-
tional activity which could underpin inter-individual
differences in susceptibility to infection. However, be-
cause this shared polymorphism occurs at a hyper-
mutable CpG site (Table 1), its candidacy as a true
TSP must be in some doubt; in the absence of any
convincing evidence that this variant is of direct func-
tional significance, it may simply be a marker in link-
age disequilibrium with another variant that is under
balancing selection.
The discovery of these putative regulatory variants
within intron 1 of the TRIM5 gene between humans
and the great apes provides evidence for the mainten-
ance of balanced regulatory polymorphisms across spe-
cies (as distinct from balanced coding sequence
variants), as well as yet another example of a TSP which
may impact the host pathogen response. Trans-species
Table 1 Properties and allelic frequencies of human single-nucleotide putative TSPs shared with bonobos and common
chimpanzees
Gene SNP ID SNP flanking sequencea MAFa AA Change Presence
ZC3HAV1 rs3735007 GTTTA(C/T)TGAAG 0.47 (C) Thr851Ile Human and common chimpanzee
TRIM5 rs34506684 TCTGG(C/T)GCCTC 0.46 (T) Intronic Human and common chimpanzee
LAD1 rs12088790 GGGCC(A/G)GCGAC 0.12 (G) Leu257Pro Human, bonobo and common chimpanzee
aData extracted from dbSNP [69]
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regulatory polymorphism has been functionally inves-
tigated at the MHC-DQA1 locus in eight non-human
primates [49]. Numerous trans-species polymorphisms
were identified within transcription factor binding sites
in the MHC-DQA1 promoter region. Loisel et al. [49]
assessed the functional consequences of these variants
using a reporter gene assay and identified significant dif-
ferences between baboon DQA1 promoter haplotypes
in terms of their ability to drive transcription in vitro.
Taken together with the high levels of sequence variation
in this region, these findings suggest a role for balancing
selection in the evolution of DQA1 transcriptional regula-
tion in primates although the biological mechanism under-
lying the assumed increase in fitness remains unclear.
More recently, a scan of the human genome yielded
good evidence for six non-coding genomic regions
where ancestral polymorphisms shared between humans
and chimpanzees have been under the influence of bal-
ancing selection [2]. The closest genes to these regions
(FREM3, MTRR, PROKR2, HUS1, IGFBP7 and ST3GAL1)
are all to some extent related to the innate immune re-
sponse, a finding which would concur with a balancing
selection mode of evolution. For three of these six re-
gions (near HUS1, IGFBP7 and ST3GAL1), a regulatory
role for the polymorphisms involved was demonstrated,
indicating that physiological differences resulting from
a balanced polymorphism can also be exerted at the
level of gene expression. A role for regulatory variants
as targets of balancing selection is not surprising since
many studies have reported an important role for het-
erozygote advantage in the evolution of gene expression
[50–52]. Although many of these variants may indi-
vidually be associated with deleterious effects, they may
nevertheless provide fitness advantages under certain
environmental conditions [51, 53] by potentiating an
optimal level of gene expression [52]. It is also quite
possible that some of these regulatory balanced alleles
have persisted for long periods of time in immunity-
related genes thereby providing further likely examples
of TSPs between humans and the great apes.
The most recently reported example of a putative
TSP is that in exon 3 of the ladinin 1 (LAD1) gene
(rs12088790) (Table 1) which has been claimed to be
maintained by long-term selection in humans, common
chimpanzees and bonobos [54]. However, once again,
the shared polymorphism occurs at a CpG dinucleotide
and hence may not in reality be identical-by-descent.
The resulting missense change (Leu257Pro) influences
the expression of LAD1: the minor allele, which occurs
at a frequency of 0.12 in humans (Table 1), is associated
with an increased level of LAD1 expression. Irrespect-
ive of whether this is a direct effect, or whether the
missense variant is in linkage disequilibrium with an-
other polymorphic variant with a regulatory role, it
provides further evidence for the important role of shared
polymorphism in modulating gene expression.
The LAD1 gene encodes a collagenous anchoring fila-
ment protein that serves to maintain dermal-epidermal
cohesion and is associated with IgA bullous dermatosis,
an autoimmune disease [55]. Apart from its pathogenic
role in the context of IgA bullous dermatosis, there is
no information as to how LAD1 might contribute to
the host response against a pathogen. However, many
autoimmune diseases are triggered by infectious agents
in addition to environmental factors [56], and this has
been specifically reported to be the case in IgA bullous
dermatosis [57].
Overdominance vs. pathogen-driven frequency-dependent
selection
The maintenance of TSP by long-term balancing selec-
tion has long been held to be mediated by heterozygote
advantage (overdominance) or frequency-dependent se-
lection [19]. Previous studies have claimed that the
most important factor for the maintenance of MHC
polymorphism is overdominant selection [58, 59]. In
support of this postulate, MHC heterozygosity has been
experimentally demonstrated to enhance resistance to
multiple-strain infections [60]. However, a simulation-
based approach has demonstrated that polymorphism
at the MHC locus results not merely from overdomi-
nant selection but also from frequency-dependent host-
pathogen coevolution for rare MHC alleles [61].
Host-pathogen interactions have also been proposed
for the ABO TSPs whose maintenance over long pe-
riods of evolutionary time may have been due in part
to coevolution with gut pathogens [62]. In accordance
with this suggestion, a general model that integrates
frequency-dependent selection and genetic drift would
appear to account for the ABO polymorphism in
humans [63]. Irrespective of the precise mechanism
underlying the maintenance of a given TSP, it is im-
portant to appreciate that to be effective, the selective
agent would need to exhibit the following properties:
(a) it must be widespread geographically, (b) it must
have been present over an extended period of evolu-
tionary time, and (c) it must show similar tropism to-
wards different yet evolutionarily related species.
Further, heterozygosity at the targeted locus would
have to mediate similar selective responses in the dif-
ferent species involved, and selection in favour of the
heterozygote would have to be sufficiently intense to
maintain the frequency of the minor allele(s) in the
host species populations. The selective agent most
likely to possess these properties is a pathogen. Alter-
native selective agents such as climate and diet would
be most unlikely to remain constant over extended
periods of evolutionary time [64].
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Conclusion
The presence of shared polymorphisms across evolution-
arily related species is a strong indicator of balancing se-
lection. Although most of the studies to date have
focussed on the classical examples of the MHC and
ABO loci, a few additional examples are known between
humans and the great apes. Herein, we have reviewed
these cases and noted that a common feature of virtually
all well-established cases of balanced TSP is their associ-
ation with the host-immune response, presumably trig-
gered by infectious agents. The diversity observed at
immunity-related loci is certainly shaped by the dynamic
process of host-pathogen coevolution [65], and there-
fore, key aspects of a species’ adaptation to challenging
environments are likely to have been pathogen-driven
[66–68]. This raises the question of the potential rele-
vance of TSP identification to improving our under-
standing of the host immune response; indeed, the study
of these ancient variants could lead to new insights into
immune system function with important implications
for preventive medicine. Finally, it may be that the iden-
tification of additional balanced TSPs in humans and
their closest relatives among the great apes might be fa-
cilitated by a guided search (e.g. by targeting immune
system/autoimmune disease-associated genes specific-
ally). The difficulty inherent in any such quest would be
to prove that a newly detected shared polymorphism is
identical-by-descent rather than simply identical-by-
state. This would be especially true for polymorphisms
residing within CpG sites where the balance of probabil-
ity must lie firmly on the side of their being identical-by-
state, at least until functional evidence to the contrary
can be provided.
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